Matthias Schnell, PhD

Contact Dr. Schnell

1020 Locust Street
Room 309
Philadelphia, PA 19107

(215) 503-4634

Most Recent Peer-reviewed Publications

  1. Inactivated recombinant rabies viruses displaying canine distemper virus glycoproteins induce protective immunity against both pathogens
  2. The final (Oral Ebola) vaccine trial on captive chimpanzees?
  3. Toward an Effective Ebola Virus Vaccine
  4. One-Health: A safe, efficient, dual-use vaccine for humans and animals against middle east respiratory syndrome coronavirus and rabies virus
  5. Keeping it in check: Chronic viral infection and antiviral immunity in the brain
  6. An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted with Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models
  7. Everything You Always Wanted to Know about Rabies Virus (But Were Afraid to Ask)
  8. Human polyclonal antibodies produced through DNA vaccination of transchromosomal cattle provide mice with post-exposure protection against lethal zaire and Sudan ebolaviruses
  9. Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics
  10. Rhabdovirus-based vaccine platforms against henipaviruses
  11. Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine
  12. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses
  13. Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs
  14. Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo
  15. Rabies virus replication and pathogenesis
  16. Small-molecule probes targeting the viral PPxY-host nedd4 interface block egress of a broad range of RNA viruses
  17. Interspecies protein substitution to investigate the role of the lyssavirus glycoprotein
  18. Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV
  19. Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity
  20. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling.